Author (year) | Protocol | Institutions, n | Blinding | Sample size (T/C) | Study design | Treatment intervention | Control intervention | Disease | Severity | Treatment period | Treatments, n | Funding |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Choi (2010) [12] | Multicenter | 4 | Single | 175 (116/59) | Parallel group | Acupuncture | Usual care | Perimenopause and post-menopause | NR | 4 weeks | 12 | Yes |
Choi (2012) [13] | Multicenter | 3 | Open | 150 (75/75) | Parallel group | Acupuncture | Usual care | Dry eye | Other | 8 weeks | 12 | Yes |
Choi (2012) a [14] | Single-center | 1 | Single | 42 (14/28) | Parallel group | Acupuncture | Distant and combination point | Temporomandibular joint disorder | Other | 2 weeks | 6 | Yes |
Choi (2015) [15] | Single-center | 1 | Single | 30 (15/15) | Parallel group | Acupuncture | No treatment | Hypertension | Other | 8 weeks | 16 | Yes |
Choi (2015) a [16] | Multicenter | 4 | Open | 150 (49/51) | Parallel group | Acupuncture | Sham acupuncture | Fatigue | Chronic | 4 weeks | 10 | Yes |
Choi (2018) [17] | Single-center | 1 | Single | 30 (15/15) | Parallel group | Acupuncture | Sham acupuncture | Functional constipation | Other | 4 weeks | 12 | Yes |
Choi (2018) a [18] | Multicenter | 4 | Single | 126 (63/63) | Parallel group | Acupuncture | Placebo | Diabetic peripheral neuropathy | Other | 8 weeks | 16 | Yes |
Han (2018) [19] | Single-center | 1 | Single | 40 (20/20) | Parallel group | Embedding acupuncture | Acupuncture | Low back pain | Chronic | 8 weeks | T4/C16 | Yes |
Jung (2009) [20] | Single-center | 1 | Double | 52 (27/25) | Parallel group | Acupuncture | Sham acupuncture | Stroke | Other | 3 days | 1 | Yes |
Kim (2010) [21] | Single-center | 1 | Double | 60 (30/30) | Parallel group | Pharmaco-acupuncture | Sham acupuncture | Osteoarthritis | Other | 6 weeks | 12 | Yes |
Kim (2018) b [22] | Multicenter | 2 | Open | 16 (9/7) | Parallel group | Acupuncture | No treatment | Liver cirrhosis | Other | 4 weeks | 12 | Yes |
Lee (2011) [23] | Single-center | 1 | Single | 54 (57/57) | Parallel group | Acupuncture | Sham acupuncture | Perimenopause and post-menopause | Other | 7 weeks | 11 | Yes |
Lee (2013) [24] | Single-center | 1 | Single | 45 (15/30) | Parallel group | Acupuncture | Usual care | Neck pain | Chronic | 3 weeks | 9 | Yes |
Lee (2018) [25] | Single-center | 1 | Double | 30 (15/15) | Parallel group | Acupuncture | Sham acupuncture | Cancer pain | Other | 3 weeks | NR | Yes |
Nam (2017) [26] | Single-center | 1 | Open | 45 (13/29) | Parallel group | Acupuncture | Electro-acupuncture | Tinnitus | Other | 4 weeks | 8 | No |
Park (2014) [27] | Single-center | 1 | Single | 61 (31/30) | Parallel group | Electro-acupuncture | Electro-acupuncture | Pain | Other | NR | 1 | Yes |
Park (2016) [28] | Multicenter | 2 | Open | 76 (37/39) | Other | Acupuncture | Acupuncture | Functional dyspepsia | Other | 4 weeks | 2 | Yes |
Shin (2018) [29] | Single-center | 1 | Single | 39 (18/21) | Parallel group | Electro-acupuncture | Usual care | Low back pain | Chronic | 4 weeks | 8 | Yes |
Song (2013) [30] | Multicenter | 3 | Double | 130 (65/65) | Parallel group | Acupuncture | Sham acupuncture | Low back pain | Chronic | 6 weeks | 12 | Yes |
Yang (2016) [31] | Single-center | 1 | Open | 50 (26/24) | Parallel group | Acupuncture | Usual care | Lumbar spinal stenosis | Other | 6 weeks | 72–96 | Yes |
Yoo (2015) [32] | Single-center | 1 | Double | 14 (7/7) | Parallel group | Acupuncture | Sham acupuncture | Thyroid cancer | Other | 2 weeks | 6 | Yes |
Chang (2018) [33] | Multicenter | 2 | Double | 140 (70/70) | Parallel group | Herbal medicine | Placebo | Children with mild short stature | Other | 24 weeks | 336 | N.R |
Jung (2012) [34] | Single-center | 1 | Double | 144 (73/71) | Parallel group | Herbal medicine | Placebo | Hwa-byung | Other | 8 weeks | 4 | Yes |
Kim (2011) [35] | Single-center | 1 | Double | 166 (110/56) | Parallel group | Herbal medicine | Other | Obesity | Other | 8 weeks | 168 | Yes |
Kim (2013) [36] | Multicenter | 2 | Double | 100 (50/50) | Parallel group | Herbal medicine | Placebo | Functional dyspepsia | Other | 6 weeks | 2 | Yes |
Kim (2014) [37] | Single-center | 1 | Double | 50 (25/25) | Parallel group | Herbal medicine | Placebo | Obesity | Other | 8 weeks | 2 T/day | Yes |
Kim (2016) [38] | Multicenter | 2 | Double | 96 (48/48) | Parallel group | Herbal medicine | Placebo | Oral mucositis | Other | 8 weeks | 2 | Yes |
Kim (2019) [39] | Single-center | 1 | Double | 60 (30/30) | Parallel group | Herbal medicine | Placebo | Allergic rhinitis | Other | 4 weeks | 2 | Yes |
Ko (2017) [40] | Single-center | 1 | Double | 32 (16/16) | Parallel group | Herbal medicine | Placebo | Cancer-related anorexia | Other | 4 weeks | 2 | Yes |
Nah (2018) [41] | Multicenter | 2 | Double | 143 (70/73) | Parallel group | Herbal medicine | Placebo | Knee osteoarthritis | Other | 6 weeks | 1 | Yes |
Son (2013) [42] | Single-center | 1 | Double | 90 (60/30) | Parallel group | Herbal medicine | Placebo | Fatigue | Chronic | 4 weeks | 1 | Yes |
Yoon (2010) [43] | Single-center | 1 | Open | 40 (20/20) | Parallel group | Herbal medicine | No treatment | Cancer-related fatigue | Other | 2 weeks | 1 | Yes |
Yoon (2018) [44] | Single-center | 1 | Open | 30 (15/15) | Parallel group | Herbal medicine | No treatment | Cancer-related sleep disturbance | Other | 2 weeks | 1 | Yes |
Choi (2011) a [45] | Single-center | 1 | Single | 26 (13/13) | Parallel group | Moxibustion | Sham moxibustion | Functional constipation | Other | 4 weeks | 12 | Yes |
Choi (2014) [46] | Multicenter | 4 | Open | 212 (102/110) | Parallel group | Moxibustion | Usual care | Knee osteoarthritis | Other | 4 weeks | 4 | Yes |
Yoo (2017) [47] | Single-center | 1 | Single | 16 (9/7) | Parallel group | Moxibustion | Sham moxibustion | Metastatic cancer | Other | 2 weeks | 10 | Yes |
Choi (2011) [48] | Single-center | 1 | Open | 32 (21/11) | Parallel group | Cupping | No treatment | Low back pain | Other | 2 week | 6 | Yes |
Hong (2012) [49] | Single-center | 1 | Open | 40 (20/20) | Parallel group | Cupping | Usual care | Neck pain | Other | 2 weeks | 6 | Yes |
Kim (2015) [50] | Single-center | 1 | Open | 27 (15/12) | Parallel group | Other | Usual care | Hwa-byung | Other | 4 weeks | 4 | Yes |
Kim (2016) a [51] | Single-center | 1 | Single | 14 (7/7) | Parallel group | Other | Placebo | Head and neck cancer | Other | 8 weeks | 4 | Yes |
Park (2018) [52] | Single-center | 1 | Double | 73 (29/29) | Parallel group | Other | Sham | Parkinson’s disease | Other | 12 weeks | 24 | Yes |
Yoon (2016) [53] | Single-center | 1 | Single | 30 (15/15) | Parallel group | Other | Usual care | Breast cancer | Other | Other | NR | Yes |
Jung (2014) [54] | Multicenter | 2 | Double | 147 (49/49/49) | Parallel group | Herbal medicine | Placebo | Anxiety disorder | Other | 8 weeks | 4 | Yes |
Kim (2018) [55] | Multicenter | 2 | Double | 96 (32/32/32) | Other | Herbal medicine | Other | Functional dyspepsia | Other | 8 weeks | 1 | Yes |
Kim (2018) a [56] | Multicenter | 2 | Double | 96 (64/32) | Parallel group | Herbal medicine | Placebo | Functional dyspepsia | Other | 8 weeks | 2 | Yes |
Kwon (2019) [57] | Single-center | 1 | Open | 24 (12/12) | Crossover | Herbal medicine | – | Healthy male volunteers | Other | Other | 1 | NR |
Park (2013) [58] | Single-center | 1 | Double | 53 (13/14/14/12) | Other | Herbal medicine | Other | Diarrhea-dominant irritable bowel syndrome | Other | 8 weeks | 1 | Yes |
Kwon (2018) [59] | Single-center | 1 | Open | 28 (14/14) | Crossover | Moxibustion | – | Overactive bladder | Other | 4 weeks | 8–12 | NR |
Kim (2012) [60] | Single-center | 1 | Open | 44 (11/11/11/11) | Other | Other | Other | Acne vulgaris | Other | 4 weeks | 8 | NR |